Skip to Content

'
Kelly K. Hunt, M.D., F.A.C.S.

Present Title & Affiliation

Primary Appointment

Professor, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX
Chief, Surgical Breast Section, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Hamill Foundation Distinguished Professorship in Honor of Dr. Richard G. Martin, Sr., Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Associate Professor, Department of Surgery, Division of Surgery, The University of Texas Health Science Center at Houston Medical School, Houston, TX
Professor, Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

1986 The University of Tennessee Center for the Health Sciences, Memphis, TN, MD, with highest honors
1982 Memphis State University, Memphis, TN, BSc, summa cum laude, Chemistry, summa cum laude

Postgraduate Training

7/1994-6/1996 Fellow in Surgical Oncology, UT M. D. Anderson Cancer Center, Houston, TX
7/1992-6/1993 Chief Resident in General Surgery, University of California Los Angeles School of Medicine, Los Angeles, CA
7/1991-6/1992 Registrar in General and Vascular Surgery, University Hospital, Queen's Medical Centre, Nottingham, England, Nottingham, Nottingham, United Kingdom
7/1990-6/1991 Assistant Resident in General Surgery, Department of Surgery, University of California Los Angeles School of Medicine, Los Angeles, CA
7/1988-6/1990 NIH Surgical Oncology & American Cancer Society Clinical Fellowship, Division of Surgical Oncology, University of California Los Angeles School of Medicine, Los Angeles, CA
7/1986-6/1988 Resident, Surgery, Department of Surgery, University of California Los Angeles School of Medicine, Los Angeles, CA

Board Certifications

2/1994 Diplomate of the American Board of Surgery
1987 Diplomate of the National Board of Medical Examiners

Selected Publications

Peer-Reviewed Original Research Articles
1. Sun B, Wingate H, Swisher SG, Keyomarsi K, Hunt KK. Absence of pRb facilitates E2F1-induced apoptosis in breast cancer cells. Cell Cycle 9(6):1-9, 3/2010. PMID: 20237430.
2. Akli S, Bui T, Wingate H, Biernacka A, Moulder S, Tucker SL, Hunt KK, Keyomarsi K. Low-molecular-weight cyclin E can bypass letrozole-induced G1 arrest in human breast cancer cells and tumors. Clin Cancer Res 16(4):1179-90, 2/15/2010. e-Pub 2/9/2010. PMCID: PMC2822889.
3. Nguyen CV, Falcón-Escobedo R, Hunt KK, Nayeemuddin KM, Lester TR, Harrell RK, Bassett RL, Gilcrease MZ. Pleomorphic Ductal Carcinoma of the Breast: Predictors of Decreased Overall Survival. Am J Surg Pathol. e-Pub 2/11/2010. PMID: 20154588.
4. Anaya DA, Lahat G, Wang X, Xiao L, Pisters PW, Cormier JN, Hunt KK, Feig BW, Lev DC, Pollock RE. Postoperative nomogram for survival of patients with retroperitoneal sarcoma treated with curative intent. Ann Oncol 21(2):397-402, 2/2010. e-Pub 7/2009. PMID: 19622598.
5. Fearmonti RM, Batista LI, Meric-Bernstam F, Bedrosian I, Kuerer HM, Hunt KK, Eva Singletary S, Babiera GV. False Negative Rate of Sentinel Lymph Node Biopsy in Multicentric and Multifocal Breast Cancers May be Higher in Cases with Large Additive Tumor Burden. Breast J 15(6):645-8, Nov-Dec, 11/2009. e-Pub 9/7/2009. PMID: 19735388.
6. Boughey JC, Goravanchi F, Parris RN, Kee SS, Kowalski AM, Frenzel JC, Bedrosian I, Meric-Bernstam F, Hunt KK, Ames FC, Kuerer HM, Lucci A. Prospective randomized trial of paravertebral block for patients undergoing breast cancer surgery. Am J Surg 198(5):720-725, 11/2009. e-Pub 5/9/2009. PMID: 19427625.
7. Smith GL, Xu Y, Shi T-C T, Giordano SH, Smith BD, Hunt KK, Strom EA, Perkins GH, Hortobagyi GN, Buchholz TA. Breast-Conserving Surgery in Older Patients with Invasicve Breast Cancer: Current Patterns of Treatment Across the United States. J Amer College of Surg 209(4):425-433, 10/2009.
8. Hunt KK, Yi M, Mittendorf EA, Guerrero C, Babiera G, Bedrosian I, Hwang RF, Kuerer HM, Ross MI, and Meric-Bernstam F. Sentinel Lymph Node Surgery after Neoadjuvant Chemotherapy is Accurate and Reduces the Need for Axillary Dissection in Breast Cancer Patients Annals of Surgery. Annals of Surg 250(4), 10/2009.
9. Lahat G, Dhuka AR, Lahat S, Lazar AJ, Lewis VO, Lin PP, Feig B, Cormier JN, Hunt KK, Pisters PW, Pollock RE, Lev D. Complete Soft Tissue Sarcoma Resection is a Viable Treatment Option for Select Elderly Patients. Ann Surg Oncol 16(9):2579-2586, 9/2009. e-Pub 6/26/2009. PMID: 19557478.
10. Boughey JC, Goravanchi F, Parris RN, Kee SS, Frenzel JC, Hunt KK, Ames FC, Kuerer HM, Lucci A. Improved Postoperative Pain Control using Thoracic Paravertebral Block for Breast Operations. Breast J 15(5):483-8, Sep-Oct, 9/2009. e-Pub 7/13/2009. PMID: 19624418.
11. Wagner J, Boughey JC, Garrett B, Babiera G, Kuerer H, Meric-Bernstam F, Singletary E, Hunt KK, Middleton LP, Bedrosian I. Margin assessment after neoadjuvant chemotherapy in invasive lobular cancer. Am J Surg 198(3):387-391, 9/2009. e-Pub 4/10/2009. PMID: 19362281.
12. Lahat G, Dhuka AR, Lahat S, Smith KD, Pollock RE, Hunt KK, Ravi V, Lazar AJ, Lev D. Outcome of Locally Recurrent and Metastatic Angiosarcoma. Ann Surg Oncol 16(9):2502-2509, 9/2009. e-Pub 6/24/2009. PMID: 19551444.
13. Blazer DG, Lazar AJ, Xing Y, Askew RL, Feig BW, Pisters PW, Pollock RE, Lev D, Hunt KK, Cormier JN. Clinical outcomes of molecularly confirmed clear cell sarcoma from a single institution and in comparison with data from the Surveillance, Epidemiology, and End Results registry. Cancer 115(13):2971-9, 7/1/2009. PMID: 19402173.
14. Wagner M, Roh V, Strehlen M, Laemmle A, Stroka D, Egger B, Trochsler M, Hunt KK, Candinas D, Vorburger SA. Effective Treatment of Advanced Colorectal Cancer by Rapamycin and 5-FU/Oxaliplatin Monitored by TIMP-1. J Gastrointest Surg. e-Pub 6/2009.
15. Boughey JC, Wagner J, Garrett BJ, Harker L, Middleton LP, Babiera GV, Meric-Bernstam F, Lucci A, Hunt KK, Bedrosian I. Neoadjuvant Chemotherapy in Invasive Lobular Carcinoma May Not Improve Rates of Breast Conservation. Ann Surg Oncol 16(6):1606-1611, 6/2009. e-Pub 3/12/2009. PMID: 19280264.
16. Lott ST, Chen N, Chandler DS, Yang Q, Wang L, Rodriguez M, Xie H, Balasenthil S, Buchholz TA, Sahin AA, Chaung K, Zhang B, Olufemi SE, Chen J, Adams H, Band V, El-Naggar AK, Frazier ML, Keyomarsi K, Hunt KK, Sen S, Haffty B, Hewitt SM, Krahe R, Killary AM. DEAR1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence-free survival in early-onset breast cancer. PLoS Med 6(5):e1000068, 5/26/2009. e-Pub 5/5/2009. PMCID: PMC2673042.
17. Krishnamurthy S, Meric-Bernstam F, Lucci A, Hwang RF, Kuerer HM, Babiera G, Ames FC, Feig BW, Ross MI, Singletary E, Hunt KK, Bedrosian I. A prospective study comparing touch imprint cytology, frozen section analysis, and rapid cytokeratin immunostain for intraoperative evaluation of axillary sentinel lymph nodes in breast cancer. Cancer 115(7):1555-62, 4/1/2009. e-Pub 2/2009. PMID: 19195040.
18. Delk NA, Hunt KK, Keyomarsi K. Altered subcellular localization of tumor-specific cyclin E isoforms affects cyclin-dependent kinase 2 complex formation and proteasomal regulation. Cancer Res 69(7):2817-2825, 4/1/2009. e-Pub 3/24/2009. PMCID: PMC2669888.
19. Lahat G, Lazar A, Wang X, Wang WL, Zhu QS, Hunt KK, Pollock RE, Lev D. Increased Vascular Endothelial Growth Factor-C Expression Is Insufficient to Induce Lymphatic metastasis in Human Soft-Tissue Sarcomas. Clin Cancer Res 15(8):2637-2646, 4/15/2009. e-Pub 4/7/2009. PMID: 19351758.
20. McAuliffe JC, Hunt KK, Lazar AJ, Choi H, Qiao W, Thall P, Pollock RE, Benjamin RS, Trent JC. A randomized, Phase II study of preoperative plus postoperative imatinib in GIST: evidence of rapid radiographic response and temporal induction of tumor cell apoptosis. Ann Surg Oncol 16(4):910-919, 4/2009. e-Pub 10/25/2008. PMID: 18953611.
21. Wingate H, Puskas A, Duong M, Bui T, Richardson D, Liu Y, Tucker SL, Van Pelt C, Meijer L, Hunt K and Keyomarsi K. Low molecular weight cyclin E is specific in breast cancer and is associated with mechanisms of tumor progression. Cell Cycle 8(7):1062-1068, 4/2009.
22. Downs-Kelly E, Nayeemuddin KM, Albarracin C, Wu Y, Hunt KK, Gilcrease MZ. Matrix-producing Carcinoma of the Breast: An Aggressive Subtype of Metaplastic Carcinoma. Am J Surg Pathol 33(4):534-41, 4/2009. e-Pub 11/26/2008. PMID: 19047898.
23. Yi M, Meric-Bernstam F, Middleton LP, Arun BK, Bedrosian I, Babiera GV, Hwang RF, Kuerer HM, Yang W, Hunt KK. Predictors of contralateral breast cancer in patients with unilateral breast cancer undergoing contralateral prophylactic mastectomy. Cancer 115(5):962-971, 3/1/2009. PMID: 19172584.
24. Yang J, Du X, Chen K, Ylipää A, Lazar AJ, Trent J, Lev D, Pollock R, Hao X, Hunt K, Zhang W. Genetic aberrations in soft tissue leiomyosarcoma. Cancer Lett 275(1):1-8, 3/2009. PMID: 18649996.
25. Cox JD, Giralt SA, Veazie ML, Ajani JA, Bruner JM, Chan KW, Hittelman WN, Hunt KK, Iyer RB, Karp DD, Kuban DA, Lippman SM, Raad II, Rodriguez-Bigas MA, Zwelling LA, Markman M. Evaluating quality in clinical cancer research: the M.D. Anderson Cancer Center experience. Oncology 77(2):75-81, 2009. e-Pub 7/1/2009. PMCID: PMC2790774.
26. Mittendorf EA, Sahin AA, Tucker SL, Meric-Bernstam F, Yi M, Nayeemuddin KM, Babiera GV, Ross MI, Feig BW, Kuerer HM, Hunt KK. Lymphovascular invasion and lobular histology are associated with increased incidence of isolated tumor cells in sentinel lymph nodes from early-stage breast cancer patients. Ann Surg Oncol 15(12):3369-77, 12/2008. PMID: 18815841.
27. Lambert LA, Qiao N, Hunt KK, Lambert DH, Mills GB, Meijer L, Keyomarsi K. Autophagy: a novel mechanism of synergistic cytotoxicity between doxorubicin and roscovitine in a sarcoma model. Cancer Res 68(19):7966-74, 10/2008. PMID: 18829554.
28. Bedi DG, Krishnamurthy R, Krishnamurthy S, Edeiken BS, Le-Petross H, Fornage BD, Bassett RL, Hunt KK. Cortical morphologic features of axillary lymph nodes as a predictor of metastasis in breast cancer: in vitro sonographic study. AJR Am J Roentgenol 191(3):646-52, 9/2008. PMID: 18716089.
29. Jeruss JS, Mittendorf EA, Tucker SL, Gonzalez-Angulo AM, Buchholz TA, Sahin AA, Cormier JN, Buzdar AU, Hortobagyi GN, Hunt KK. Staging of breast cancer in the neoadjuvant setting. Cancer Res 68(16):6477-81, 8/15/2008. PMID: 18701468.
30. Pataer A, Hu W, Xiaolin L, Chada S, Roth JA, Hunt KK, Swisher SG. Adenoviral endoplasmic reticulum-targeted mda-7/interleukin-24 vector enhances human cancer cell killing. Mol Cancer Ther 7(8):2528-35, 8/2008. PMID: 18723497.
31. Yang J, Du X, Lazar AJ, Pollock R, Hunt K, Chen K, Hao X, Trent J, Zhang W. Genetic aberrations of gastrointestinal stromal tumors. Cancer 113(7):1532-1543, 7/31/2008. PMID: 18671247.
32. Wang-Johanning F, Radvanyi L, Rycaj K, Plummer JB, Yan P, Sastry KJ, Piyathilake CJ, Hunt KK, Johanning GL. Human endogenous retrovirus K triggers an antigen-specific immune response in breast cancer patients. Cancer Res 68(14):5869-77, 7/15/2008. PMID: 18632641.
33. Olson JA, McCall LM, Beitsch P, Whitworth PW, Reintgen DS, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Giuliano AE, Giuliano AE. Impact of immediate versus delayed axillary node dissection on surgical outcomes in breast cancer patients with positive sentinel nodes: results from American College of Surgeons Oncology Group Trials Z0010 and Z0011. J Clin Oncol 26(21):3530-5, 7/20/2008. PMID: 18640934.
34. Buchholz TA, Woodward WA, Duan Z, Fang S, Oh JL, Tereffe W, Strom EA, Perkins GH, Yu TK, Hunt KK, Meric-Bernstam F, Hortobagyi GN, Giordano SH. Radiation use and long-term survival in breast cancer patients with T1, T2 primary tumors and one to three positive axillary lymph nodes. Int J Radiat Oncol Biol Phys 71(4):1022-7, 7/15/2008. e-Pub 1/30/2008. PMID: 18234447.
35. Chen LL, Holden JA, Choi H, Zhu J, Wu EF, Jones KA, Ward JH, Andtbacka RH, Randall RL, Scaife CL, Hunt KK, Prieto VG, Raymond AK, Zhang W, Trent JC, Benjamin RS, Frazier ML. Evolution from heterozygous to homozygous KIT mutation in gastrointestinal stromal tumor correlates with the mechanism of mitotic nondisjunction and significant tumor progression. Mod Pathol 21(7):826-36, 7/2008. e-Pub 5/16/2008. PMID: 18488000.
36. Yi M, Krishnamurthy S, Kuerer HM, Meric-Bernstam F, Bedrosian I, Ross MI, Ames FC, Lucci A, Hwang RF, Hunt KK. Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancer. Am J Surg 196(1):81-7, 7/2008. e-Pub 4/23/2008. PMID: 18436181.
37. Jeruss JS, Newman LA, Ayers GD, Cristofanilli M, Broglio KR, Meric-Bernstam F, Yi M, Waljee JF, Ross MI, Hunt KK. Factors predicting additional disease in the axilla in patients with positive sentinel lymph nodes after neoadjuvant chemotherapy. Cancer 112(12):2646-54, 6/15/2008. PMID: 18442039.
38. Roh V, Laemmle A, Von Holzen U, Stroka D, Dufour JF, Hunt KK, Candinas D, Vorburger SA. Dual induction of PKR with E2F-1 and IFN-alpha to enhance gene therapy against hepatocellular carcinoma. Cancer Gene Ther 15(10):636-44, 6/2008. PMID: 18535617.
39. Rao R, Feng L, Kuerer HM, Singletary SE, Bedrosian I, Hunt KK, Ross MI, Hortobagyi GN, Feig BW, Ames FC, Babiera GV. Timing of surgical intervention for the intact primary in stage IV breast cancer patients. Ann Surg Oncol 15(6):1696-702, 6/2008. e-Pub 3/21/2008. PMID: 18357493.
40. Badgwell BD, Giordano SH, Duan ZZ, Fang S, Bedrosian I, Kuerer HM, Singletary SE, Hunt KK, Hortobagyi GN, Babiera G. Mammography before diagnosis among women age 80 years and older with breast cancer. J Clin Oncol 26(15):2482-8, 5/20/2008. e-Pub 4/21/2008. PMID: 18427152.
41. Al-Refaie WB, Andtbacka RH, Ensor J, Pisters PW, Ellis TL, Shrout A, Hunt KK, Cormier JN, Pollock RE, Feig BW. Lymphadenectomy for isolated lymph node metastasis from extremity soft-tissue sarcomas. Cancer 112(8):1821-6, 4/15/2008. PMID: 18306370.
42. Bristol IJ, Woodward WA, Strom EA, Cristofanilli M, Domain D, Singletary SE, Perkins GH, Oh JL, Yu TK, Terrefe W, Sahin AA, Hunt KK, Hortobagyi GN, Buchholz TA. Locoregional treatment outcomes after multimodality management of inflammatory breast cancer. Int J Radiat Oncol Biol Phys 72(2):474-84, 4/2008. PMID: 18439768.
43. Jeruss JS, Mittendorf EA, Tucker SL, Gonzalez-Angulo AM, Buchholz TA, Sahin AA, Cormier JN, Buzdar AU, Hortobagyi GN, Hunt KK. Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapy. J Clin Oncol 26(2):246-52, 1/10/2008. e-Pub 12/3/2007. PMID: 18056680.
44. Shaye A, Sahin A, Hao Q, Hunt K, Keyomarsi K, Bedrosian I. Cyclin E deregulation is an early event in the development of breast cancer. Breast Cancer Res Treat, 2008. e-Pub 12/2008.
45. Boughey JC, Cormier JN, Xing Y, Hunt KK, Meric-Bernstam F, Babiera GV, Ross MI, Kuerer HM, Singletary SE, Bedrosian I. Decision analysis to assess the efficacy of routine sentinel lymphadenectomy in patients undergoing prophylactic mastectomy. Cancer 110(11):2542-50, 12/1/2007. PMID: 17932905.
46. Yokota T, Bui T, Liu Y, Yi M, Hunt KK, Keyomarsi K. Differential regulation of elafin in normal and tumor-derived mammary epithelial cells is mediated by CCAAT/enhancer binding protein beta. Cancer Res 67(23):11272-83, 12/1/2007. PMID: 18056453.
47. Oh JL, Nguyen G, Whitman GJ, Hunt KK, Yu TK, Woodward WA, Tereffe W, Strom EA, Perkins GH, Buchholz TA. Placement of radiopaque clips for tumor localization in patients undergoing neoadjuvant chemotherapy and breast conservation therapy. Cancer 110(11):2420-7, 12/1/2007. PMID: 17941034.
48. Yang WT, Hennessy B, Broglio K, Mills C, Sneige N, Davis WG, Valero V, Hunt KK, Gilcrease MZ. Imaging differences in metaplastic and invasive ductal carcinomas of the breast. AJR Am J Roentgenol 189(6):1288-93, 12/2007. PMID: 18029860.
49. Kronowitz SJ, Hunt KK, Kuerer HM, Strom EA, Buchholz TA, Ensor JE, Koutz CA, Robb GL. Practical guidelines for repair of partial mastectomy defects using the breast reduction technique in patients undergoing breast conservation therapy. Plast Reconstr Surg 120(7):1755-68, 12/2007. PMID: 18090737.
50. Pataer A, Chada S, Roth JA, Hunt KK, Swisher SG. Development of Ad-mda7/IL-24-resistant lung cancer cell lines. Cancer Biol Ther 7(1):103-8, 10/13/2007. e-Pub 10/13/2007. PMID: 18059175.
51. von Holzen U, Pataer A, Raju U, Bocangel D, Vorburger SA, Liu Y, Lu X, Roth JA, Aggarwal BB, Barber GN, Keyomarsi K, Hunt KK, Swisher SG. The double-stranded RNA-activated protein kinase mediates radiation resistance in mouse embryo fibroblasts through nuclear factor kappaB and Akt activation. Clin Cancer Res 13(20):6032-9, 10/15/2007. PMID: 17947465.
52. Vo T, Xing Y, Meric-Bernstam F, Mirza N, Vlastos G, Symmans WF, Perkins GH, Buchholz TA, Babiera GV, Kuerer HM, Bedrosian I, Akins JS, Hunt KK. Long-term outcomes in patients with mucinous, medullary, tubular, and invasive ductal carcinomas after lumpectomy. Am J Surg 194(4):527-31, 10/2007. PMID: 17826073.
53. Pisters PW, Pollock RE, Lewis VO, Yasko AW, Cormier JN, Respondek PM, Feig BW, Hunt KK, Lin PP, Zagars G, Wei C, Ballo MT. Long-term results of prospective trial of surgery alone with selective use of radiation for patients with T1 extremity and trunk soft tissue sarcomas. Ann Surg 246(4):675-81; discussion 681-2, 10/2007. PMID: 17893504.
54. Boughey JC, Middleton LP, Harker L, Garrett B, Fornage B, Hunt KK, Babiera GV, Dempsey P, Bedrosian I. Utility of ultrasound and fine-needle aspiration biopsy of the axilla in the assessment of invasive lobular carcinoma of the breast. Am J Surg 194(4):450-5, 10/2007. PMID: 17826054.
55. Hwang RF, Gonzalez-Angulo AM, Yi M, Buchholz TA, Meric-Bernstam F, Kuerer HM, Babiera GV, Tereffe W, Liu DD, Hunt KK. Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection. Cancer 110(4):723-30, 8/15/2007. PMID: 17587208.
56. Williams SA, Ehlers RA, Hunt KK, Yi M, Kuerer HM, Singletary SE, Ross MI, Feig BW, Symmans WF, Meric-Bernstam F. Metastases to the breast from nonbreast solid neoplasms: presentation and determinants of survival. Cancer 110(4):731-7, 8/15/2007. PMID: 17582626.
57. Hayes-Jordan A, Anderson P, Curley S, Herzog C, Lally KP, Green HL, Hunt K, Mansfield P. Continuous hyperthermic peritoneal perfusion for desmoplastic small round cell tumor. J Pediatr Surg 42(8):E29-32, 8/2007. PMID: 17706484.
58. Lucci A, McCall LM, Beitsch PD, Whitworth PW, Reintgen DS, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Giuliano AE. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol 25(24):3657-63, 8/2007. PMID: 17485711.
59. McGuire SE, Gonzalez-Angulo AM, Huang EH, Tucker SL, Kau SW, Yu TK, Strom EA, Oh JL, Woodward WA, Tereffe W, Hunt KK, Kuerer HM, Sahin AA, Hortobagyi GN, Buchholz TA. Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy. Int J Radiat Oncol Biol Phys 68(4):1004-9, 7/15/2007. PMID: 17418973.
60. Sher T, Hennessy BT, Valero V, Broglio K, Woodward WA, Trent J, Hunt KK, Hortobagyi GN, Gonzalez-Angulo AM. Primary angiosarcomas of the breast. Cancer 110(1):173-8, 7/1/2007. PMID: 17541936.
61. Lu J, Wei Q, Bondy ML, Brewster AM, Bevers TB, Yu TK, Buchholz TA, Meric-Bernstam F, Hunt KK, Singletary SE, Wang LE. Genetic variants in the H2AFX promoter region are associated with risk of sporadic breast cancer in non-Hispanic white women aged </=55 years. Breast Cancer Res Treat 110(2):357-66, 2008, 7/2007. PMID: 17851762.
62. Shen J, Gilcrease MZ, Babiera GV, Ross MI, Meric-Bernstam F, Feig BW, Kuerer HM, Francis A, Ames FC, Hunt KK. Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases. Cancer 109(7):1255-63, 4/1/2007. PMID: 17330229.
63. Cabioglu N, Hunt KK, Sahin AA, Kuerer HM, Babiera GV, Singletary SE, Whitman GJ, Ross MI, Ames FC, Feig BW, Buchholz TA, Meric-Bernstam F. Role for intraoperative margin assessment in patients undergoing breast-conserving surgery. Ann Surg Oncol 14(4):1458-71, 4/2007. PMID: 17260108.
64. Yang WT, Hennessy BT, Dryden MJ, Valero V, Hunt KK, Krishnamurthy S. Mammary angiosarcomas: imaging findings in 24 patients. Radiology 242(3):725-34, 3/2007. PMID: 17325063.
65. Price ND, Trent J, El-Naggar AK, Cogdell D, Taylor E, Hunt KK, Pollock RE, Hood L, Shmulevich I, Zhang W. Highly accurate two-gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomas. Proc Natl Acad Sci U S A 104(9):3414-9, 2/27/2007. PMID: 17360660.
66. Huang EH, Strom EA, Valero V, Fornage B, Perkins GH, Oh JL, Yu TK, Tereffe W, Woodward WA, Hunt KK, Meric-Bernstam F, Sahin AA, Bedrosian I, Hortobagyi GN, Buchholz TA. Locoregional treatment outcomes for breast cancer patients with ipsilateral supraclavicular metastases at diagnosis. Int J Radiat Oncol Biol Phys 67(2):490-6, 2/1/2007. PMID: 17236970.
67. Buzdar AU, Valero V, Ibrahim NK, Francis D, Broglio KR, Theriault RL, Pusztai L, Green MC, Singletary SE, Hunt KK, Sahin AA, Esteva F, Symmans WF, Ewer MS, Buchholz TA, Hortobagyi GN. Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: an update of the initial randomized study population and data of additional patients treated with the same regimen. Clin Cancer Res 13(1):228-33, 1/1/2007. PMID: 17200359.
68. Pataer A, Bocangel D, Chada S, Roth JA, Hunt KK, Swisher SG. Enhancement of adenoviral MDA-7-mediated cell killing in human lung cancer cells by geldanamycin and its 17-allyl- amino-17-demethoxy analogue. Cancer Gene Ther 14(1):12-8, 1/2007. PMID: 17024233.
69. Ballo MT, Zagars GK, Pollock RE, Benjamin RS, Feig BW, Cormier JN, Hunt KK, Patel SR, Trent JC, Beddar S, Pisters PW. Retroperitoneal soft tissue sarcoma: an analysis of radiation and surgical treatment. Int J Radiat Oncol Biol Phys 67(1):158-63, 1/2007. PMID: 17084545.
70. Andtbacka RH, Ng CS, Scaife CL, Cormier JN, Hunt KK, Pisters PW, Pollock RE, Benjamin RS, Burgess MA, Chen LL, Treng J, patel SR, Raymond K, Feig BW. Surgical resection of gastrointestinal stromal tumors after treatment with imatinib. Ann Surg Oncol 14(1):14-24, 1/2007.
71. Feng W, Shen L, Wen S, Rosen DG, Jelinek J, Hu X, Huan S, Huang M, Liu J, Sahin AA, Hunt KK, Bast RC, Shen Y, Issa JP, Yu Y. Correlation between CpG methylation profiles and hormone receptor status in breast cancers. Breast Cancer Res 9(4):R57, 2007. PMID: 17764565.
72. Huang EH, Strom EA, Perkins GH, Oh JL, Chen AM, Meric-Bernstam F, Hunt KK, Sahin AA, Hortobagyi GN, Buchholz TA. Comparison of risk of local-regional recurrence after mastectomy or breast conservation therapy for patients treated with neoadjuvant chemotherapy and radiation stratified according to a prognostic index score. Int J Radiat Oncol Biol Phys, 8/2006. PMID: 16887286.
73. Pataer A, Fanale MA, Roth JA, Swisher SG, Hunt KK. Induction of apoptosis in human lung cancer cells following treatment with amifostine and an adenoviral vector containing wild-type p53. Cancer Gene Ther 13(8):806-14, 8/2006. PMID: 16628227.
74. Boughey JC, Ross MI, Babiera GV, Bedrosian I, Feig BW, Hwang RF, Kuerer HM, Hunt KK. Sentinel lymph node surgery in locally recurrent breast cancer. Clin Breast Cancer 7(3):248-53, 8/2006. PMID: 16942642.
75. Peintinger F, Symmans WF, Gonzalez-Angulo AM, Boughey JC, Buzdar AU, Yu TK, Hunt KK, Singletary SE, Babiera GV, Lucci A, Meric-Bernstam F, Kuerer HM. The safety of breast-conserving surgery in patients who achieve a complete pathologic response after neoadjuvant chemotherapy. Cancer 107(6):1248-1254, 7/2006. PMID: 16862596.
76. Kawase K, Gayed IW, Hunt KK, Kuerer HM, Akins J, Yi M, Grimes L, Babiera GV, Ross MI, Feig BW, Ames FC, Singletary SE, Buchholz TA, Symmans WF, Meric-Bernstam F. Use of lymphoscintigraphy defines lymphatic drainage patterns before sentinel lymph node biopsy for breast cancer. J Am Coll Surg 203(1):64-72, 7/2006. PMID: 16798488.
77. Bocangel D, Zheng M, Mhashilkar A, Liu Y, Ramesh R, Hunt KK, Chada S. Combinatorial synergy induced by adenoviral-mediated mda-7 and Herceptin in Her-2+ breast cancer cells. Cancer Gene Ther, 6/2006. PMID: 16783343.
78. Babiera GV, Rao R, Feng L, Meric-Bernstam F, Kuerer HM, Singletary SE, Hunt KK, Ross MI, Gwyn KM, Feig BW, Ames FC, Hortobagyi GN. Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor. Ann Surg Oncol 13(6):776-82, 6/2006. PMID: 16614878.
79. Swisher SG, Schmit PJ, Hunt KK, Hiyama DT, Bennion RS, Swisher EM, Thompson JE. Biliary disease during pregnancy. Am J Surg 168(6):576-9; discussion 580-1, 12/1994. PMID: 7977999.
80. Swisher SG, Hunt KK, Schmit PJ, Hiyama DT, Bennion RS, Thompson JE. Management of pancreatitis complicating pregnancy. Am Surg 60(10):759-62, 10/1994. PMID: 7944038.
81. Swisher SG, Cates JA, Hunt KK, Robert ME, Bennion RS, Thompson JE, Roslyn JJ, Reber HA. Pancreatitis associated with adult choledochal cysts. Pancreas 9(5):633-7, 9/1994. PMID: 7809018.
82. Miller AR, McBride WH, Hunt KK, Economou JS. Cytokine-mediated gene therapy for cancer. Ann Surg Oncol 1(5):436-50, 1994.
83. Alvarez C, Hunt KK, Ashley SW, Reber HA. Emphysematous cholecystitis after ERCP. Dig Dis Sci 39(8):17, 19-23, 1994.
84. Hunt KK, Shibata M, Gupta RK, Morton DL. Complement-dependent lysis of tumor cells by a baboon IgM antibody to a tumor-associated antigen. Cancer Immunol Immunother 34(6):377-82, 1992. PMID: 1563014.

Book Chapters
1. Fearmonti RM, Keyomarsi K, Hunt KK. Biomarkers in Neoadjuvant Trials. In: Hormone Receptors in Breast Cancer. Ed(s) Fuqua SAW. In Press.
2. Hunt KK, Newman LA, Copeland EM, Bland KI. The Breast. In: Schwartz’s Principles of Surgery, 9th ed. 9th. Ed(s) Brunicardi FC, Andersen DK, Billiar TR, Dunn DL, Hunter JG, Pollock RE. McGraw-Hill. In Press.
3. Buchholz TA, Hunt KK. Breast-Conserving Therapy: Conventional Whole Breast Irradiation. In: Diseases of the Breast, 4th ed. 4th. Ed(s) Harris JR, Lippman ME, Morrow M, Osborne CK. Lippincott Williams & Wilkins: Philadelphia, PA, 507-528, 2010.
4. Ching CD, Hunt KK. Percutaneous Ablation: Minimally Invasive Techniques in Breast Cancer Therapy. In: The Breast: Comprehensive Management of Benign and Malignant Diseases. 1, 4th. Ed(s) Bland KI, Copeland EM. Saunders (Elsevier), 1043-1050, 2009.
5. Fearmonti RM, Beahm EK, Pollock RE, Hunt KK. Surgical Procedures for Advanced Local and Regional Malignancies of the Breast. In: The Breast: Comprehensive Management of Benign and Malignant Diseases,. 1, 4th. Ed(s) Bland KI, Copeland EM. Saunders (Elsevier), 1147-1173, 2009.
6. Hunt, KK. Kelly K. Hunt. In: Legends and Legacies: Personal Journeys of Women Physicians and Scientists at M. D. Anderson Cancer Center, 1st, 52-60, 2008.
7. Strom EA, Buzdar AU, Hunt KK. Multidisciplinary care of breast cancer patients: Overview and implementation. In: M. D. Anderson Cancer Care Series: Breast Cancer, 2nd ed. Ed(s) Hunt KK, Robb GL, Strom EA, Ueno N. Springer: New York, NY, 197-234, 2008.
8. Boughey JC, Beahm EK, Hunt KK. Oncoplastic surgery for breast cancer. In: Textbook of Surgical Oncology. Ed(s) Poston GJ, Beauchamp D, Ruers T. Informa Healthcare: London & New York, 2008. PMID: 9781841845074.
9. McKenzie-Johnson T, Sahin A, Hunt KK. Sentinel lymph node dissection: Indications, technique and results. In: Advanced Therapy in Surgical Oncology. Ed(s) Pollock RE, Ross MI, Curley SA, Perrier ND. BC Decker Inc: Hamilton, Ontario, 511-22, 2008.
10. Hunt KK. American College of Surgeons Oncology Group (ACOSOG). In: BIG – An overview of recent & ongoing clinical trials for breast cancer, 4th ed. Cambridge University Press: UK, 2007.
11. Chada S, Bocangel D, Pataer A, Mhashilkar AM, Inoue S, Miyahara R, Roth JA, Grimm EA, Swisher SG, Hunt KK, Ramesh R. MDA-7/IL-24 as a multi-modality therapy for cance. In: Gene Therapy for Cancer. Ed(s) Hunt KK, Vorburger SA, Swisher, SG. Humana Press: Totowa, NJ, 413-34, 2007.
12. Andtbacka RHI, Meric-Bernstam F, Robinson EK, Hunt KK. Noninvasive breast cancer. In: The M. D. Anderson Surgical Oncology Handbook, 4th ed. Ed(s) Feig BW, Burger DH, Fuhrman GM. Lippincott Williams and Wilkins: Philadelphia, PA, 1-22, 2006.
13. Browne TS, Chagpar A, Hunt KK, Ramirez P. Perioperative care for breast and gynecological neoplasms. In: Acute Care of the Cancer Patient; (pending info), 433-53, 2005.
14. Bedrosian I, Bland K, Hunt KK. Follow-up care of the breast cancer patient. In: The Breast: Comprehensive Management of Benign and Malignant Diseases. Saunders (Elsevier) and W.B. Saunders Company, 1513-32, 2004.
15. Beahm EK, Pollock R, Hunt KK. Surgical procedures for advanced local and regional malignancies of the breast. In: The Breast: Comprehensive Management of Benign and Malignant Diseases. Saunders (Elsevier) and W.B. Saunders Company, 1235-54, 2004.
16. Meric F, Robinson E, Hunt KK. Noninvasive breast cancer. In: The M. D. Anderson Surgical Oncology Handbook. Lippincott Williams and Wilkins, 1-13, 2003.
17. Chagpar A Hunt KK. Urogenital neoplasms - renal, bladder, prostate and testicular, gynecologic and breast. In: Perioperative Cancer Medicine: Anesthesia, Critical Care and Pain Control in Cancer Patients. Marcel Dekker Inc, 2003.
18. Vorburger SA Hunt KK. Experimental Approaches. In: Soft Tissue Sarcoma. BC Decker Inc, 375-90, 2002.
19. Bilimoria MM Hunt KK. Stromal tumors of the stomach and small bowel. In: The Practice of General Surgery. W. B. Saunders Company, 405-8, 2002.
20. Hunt KK, Vorburger S, Cormier JN. Surgical approaches to extremity sarcoma. In: Soft Tissue Sarcoma. BC Decker Inc, 89-109, 2002.
21. Strom EA, Buzdar AU, Hunt KK. Multidisciplinary care of the breast cancer patient: Overview and implementation. In: M.D. Anderson Cancer Care Series, Breast Cancer. Springer, 1-19, 2001.
22. Meric F Hunt KK. Surgical options for breast cancer. In: M.D. Anderson Cancer Care Series, Breast Cancer. Springer, 187-222, 2001.
23. Hunt KK Buzdar AU. Breast conservation after tumor downstaging with induction chemotherapy. In: Breast Cancer: The M.D. Anderson Solid Tumor Oncology Series. Springer-Verlag, 196-207, 1999.
24. Robinson E Hunt KK. Noninvasive breast cancer. In: The M. D. Anderson Surgical Oncology Handbook. Lippincott Williams and Wilkins, 1-2, 1999.
25. Hunt KK Ross MI. Paget's disease of the nipple-areolar complex. In: Breast Cancer: The M.D. Anderson Solid Tumor Oncology Series. Springer-Verlag, 262-72, 1999.
26. Ross MI Hunt KK. Role for lymphatic mapping and sentinel node biopsy in management of early-stage breast cancer. In: Breast Cancer: The M.D. Anderson Solid Tumor Oncology Series. Springer-Verlag, 171-83, 1999.
27. Hunt KK, Patel SR, Pollack A. Soft tissue sarcomas. In: Integrated Cancer Management: Surgery, Medical Oncology and Radiation Therapy. Marcel Dekker, Inc, 394-415, 1999.
28. Hunt KK, Singletary SE, Smith TL, Ross MI, Strom EA, McNeese MD, Ames FC. Conservation surgery and radiation: The M. D. Anderson Cancer Center experience. In: The Breast: Comprehensive Management of Benign and Malignant Diseases. W.B. Saunders Company, 1179-82, 1998.
29. Hunt KK, Bland KI, Ellis LM. General considerations for follow-up. In: The Breast: Comprehensive Management of Benign and Malignant Diseases. W.B. Saunders Company, 1460-74, 1998.
30. Hunt KK, Kroll SS, Pollock RE. Surgical procedures for advanced local and regional malignancies of the breast. In: The Breast: Comprehensive Management of Benign and Malignant Diseases,.B. Saunders Company, 1234-43, 1998.
31. Hunt KK Ross MI. Changing trends in the diagnosis and treatment of early breast cancer. In: Surgical Oncology. Norwell, MA, 171-201, 1997.
32. Mansfield PF, Hunt KK. Classification, staging, and management of Non-Hodgkin's lymphomas. In: Surgical Oncology. Ed(s) Pollock RE. Kluwer Academic Publishers: Norwell, MA, 203-11, 1997.
33. Love SM Hunt KK. Diagnostic approaches to breast masses. In: Mastery of Surgery. Little Brown and Company, 563-9, 1997.
34. Hunt KK Love S. Breast Disorders. In: McGraw-Hill Encyclopedia of Science and Technology. McGraw-Hill, Inc, 1996.
35. Morton DL, Hunt KK, Bauer RL, Lee JD. Immunotherapy by active immunization of the host using nonspecific agents: Clinical applications using intralesional therapy. In: Biologic Therapy of Cancer: Principles and Practice. J.B. Lippincott Company, 627-42, 1991.
36. Torres, KE, Pollock RE and Hunt KK. Forequarter Amputation. In: Master Techniques in Breast Surgery. Submitted.
37. Hunt KK and Boughey JC. The ACOSOG Experience. In: Kuerer’s Breast Surgical Oncology. Ed(s) Kuerer H. Submitted.

Last updated: 3/19/2010